# The Visceral Adiposity Measurement and Observation Study

> **NCT05383456** · — · COMPLETED · sponsor: **Theratechnologies** · enrollment: 196 (actual)

## Conditions studied

- HIV
- HIV-Infections
- HIV-1-infection
- HIV I Infection
- HIV Lipodystrophy
- HIV Infection Primary
- HIV-Associated Lipodystrophy
- HIV Disease Progression
- Lipohypertrophy
- Liver Diseases
- NAFLD
- NASH
- Liver Fibrosis
- Hepatic Fibrosis
- Waist Circumference
- BMI
- Ectopic Fat
- Liver Fat
- Hepatic Steatosis

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test
- **DRUG:** HIV Anti-retroviral Background Therapy

## Key facts

- **NCT ID:** NCT05383456
- **Lead sponsor:** Theratechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-18
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-30
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05383456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05383456, "The Visceral Adiposity Measurement and Observation Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05383456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*